Kala Pharmaceuticals, Inc. announced that Gregory Grunberg, Managing Director at Longitude Capital, and Chen Yu, Managing Partner at Vivo Capital, joined as new Board members. Rajeev Shah, Managing Director and Portfolio Manager at RA Capital Management, joined the company's Board of Directors last year. Jonathan Silverstein, Partner and a Co-Head of Global Private Equity at OrbiMed, will hold a Board observer seat.